Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2003 | 2 |
2005 | 3 |
2006 | 1 |
2007 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Marmoset monkey models of Parkinson's disease: which model, when and why?
Brain Res Bull. 2005 Dec 30;68(3):140-9. doi: 10.1016/j.brainresbull.2005.08.005. Epub 2005 Sep 7.
Brain Res Bull. 2005.
PMID: 16325013
Review.
Assessment of GDNF in primate models of Parkinson's disease: comparison with human studies.
Eslamboli A.
Eslamboli A.
Rev Neurosci. 2005;16(4):303-10. doi: 10.1515/revneuro.2005.16.4.303.
Rev Neurosci. 2005.
PMID: 16519007
Review.
Item in Clipboard
Time-dependent increase in Nogo-A expression after focal cerebral ischemia in marmoset monkeys.
Eslamboli A, Grundy RI, Irving EA.
Eslamboli A, et al.
Neurosci Lett. 2006 Nov 13;408(2):89-93. doi: 10.1016/j.neulet.2006.08.056. Epub 2006 Sep 18.
Neurosci Lett. 2006.
PMID: 16982144
Item in Clipboard
Sensorimotor deficits in a unilateral intrastriatal 6-OHDA partial lesion model of Parkinson's disease in marmoset monkeys.
Eslamboli A, Baker HF, Ridley RM, Annett LE.
Eslamboli A, et al.
Exp Neurol. 2003 Oct;183(2):418-29. doi: 10.1016/s0014-4886(03)00139-0.
Exp Neurol. 2003.
PMID: 14552882
Item in Clipboard
Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain.
Eslamboli A, Romero-Ramos M, Burger C, Bjorklund T, Muzyczka N, Mandel RJ, Baker H, Ridley RM, Kirik D.
Eslamboli A, et al.
Brain. 2007 Mar;130(Pt 3):799-815. doi: 10.1093/brain/awl382. Epub 2007 Feb 15.
Brain. 2007.
PMID: 17303591
Item in Clipboard
Continuous low-level glial cell line-derived neurotrophic factor delivery using recombinant adeno-associated viral vectors provides neuroprotection and induces behavioral recovery in a primate model of Parkinson's disease.
Eslamboli A, Georgievska B, Ridley RM, Baker HF, Muzyczka N, Burger C, Mandel RJ, Annett L, Kirik D.
Eslamboli A, et al.
J Neurosci. 2005 Jan 26;25(4):769-77. doi: 10.1523/JNEUROSCI.4421-04.2005.
J Neurosci. 2005.
PMID: 15673656
Free PMC article.
Item in Clipboard
Recombinant adeno-associated viral vector (rAAV) delivery of GDNF provides protection against 6-OHDA lesion in the common marmoset monkey (Callithrix jacchus).
Eslamboli A, Cummings RM, Ridley RM, Baker HF, Muzyczka N, Burger C, Mandel RJ, Kirik D, Annett LE.
Eslamboli A, et al.
Exp Neurol. 2003 Nov;184(1):536-48. doi: 10.1016/j.expneurol.2003.08.007.
Exp Neurol. 2003.
PMID: 14637123
Item in Clipboard
Cite
Cite